These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 28162792)

  • 1. Synthetic Pot: Not Your Grandfather's Marijuana.
    Ford BM; Tai S; Fantegrossi WE; Prather PL
    Trends Pharmacol Sci; 2017 Mar; 38(3):257-276. PubMed ID: 28162792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?
    Fantegrossi WE; Moran JH; Radominska-Pandya A; Prather PL
    Life Sci; 2014 Feb; 97(1):45-54. PubMed ID: 24084047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marijuana-based drugs: innovative therapeutics or designer drugs of abuse?
    Seely KA; Prather PL; James LP; Moran JH
    Mol Interv; 2011 Feb; 11(1):36-51. PubMed ID: 21441120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites.
    Tai S; Fantegrossi WE
    Curr Top Behav Neurosci; 2017; 32():249-262. PubMed ID: 28012093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.
    Brents LK; Prather PL
    Drug Metab Rev; 2014 Feb; 46(1):72-85. PubMed ID: 24063277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Mechanisms Underlying the Deleterious Effects of Synthetic Cannabinoids Found in Spice/K2 Products.
    Basavarajappa BS; Subbanna S
    Brain Sci; 2019 Jan; 9(1):. PubMed ID: 30654473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids.
    Sholler DJ; Huestis MA; Amendolara B; Vandrey R; Cooper ZD
    Pharmacol Biochem Behav; 2020 Dec; 199():173059. PubMed ID: 33086126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel halogenated synthetic cannabinoids impair sensorimotor functions in mice.
    Bilel S; Tirri M; Arfè R; Ossato A; Trapella C; Serpelloni G; Neri M; Fattore L; Marti M
    Neurotoxicology; 2020 Jan; 76():17-32. PubMed ID: 31610187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic Cannabinoids.
    Mills B; Yepes A; Nugent K
    Am J Med Sci; 2015 Jul; 350(1):59-62. PubMed ID: 26132518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of hippocampal synaptic transmission and long-term potentiation by psychoactive synthetic cannabinoid 'Spice' compounds: comparison with Δ
    Hoffman AF; Lycas MD; Kaczmarzyk JR; Spivak CE; Baumann MH; Lupica CR
    Addict Biol; 2017 Mar; 22(2):390-399. PubMed ID: 26732435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Δ(9)-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids in mice and rats.
    Gatch MB; Forster MJ
    Psychopharmacology (Berl); 2016 May; 233(10):1901-10. PubMed ID: 26875756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of classical cannabinoids and the synthetic cannabinoid JWH-018.
    Su MK; Seely KA; Moran JH; Hoffman RS
    Clin Pharmacol Ther; 2015 Jun; 97(6):562-4. PubMed ID: 25788107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spicing Up Pharmacology: A Review of Synthetic Cannabinoids From Structure to Adverse Events.
    Davidson C; Opacka-Juffry J; Arevalo-Martin A; Garcia-Ovejero D; Molina-Holgado E; Molina-Holgado F
    Adv Pharmacol; 2017; 80():135-168. PubMed ID: 28826533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K2--not the spice of life; synthetic cannabinoids and ST elevation myocardial infarction: a case report.
    McKeever RG; Vearrier D; Jacobs D; LaSala G; Okaneku J; Greenberg MI
    J Med Toxicol; 2015 Mar; 11(1):129-31. PubMed ID: 25154434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotoxic Properties of Synthetic Cannabinoids on TK6 Human Cells by Flow Cytometry.
    Lenzi M; Cocchi V; Cavazza L; Bilel S; Hrelia P; Marti M
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32050487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA.
    Gamage TF; Farquhar CE; Lefever TW; Marusich JA; Kevin RC; McGregor IS; Wiley JL; Thomas BF
    J Pharmacol Exp Ther; 2018 May; 365(2):437-446. PubMed ID: 29549157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic legal intoxicating drugs: the emerging 'incense' and 'bath salt' phenomenon.
    Jerry J; Collins G; Streem D
    Cleve Clin J Med; 2012 Apr; 79(4):258-64. PubMed ID: 22473725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convulsant Effects of Abused Synthetic Cannabinoids JWH-018 and 5F-AB-PINACA Are Mediated by Agonist Actions at CB1 Receptors in Mice.
    Wilson CD; Tai S; Ewing L; Crane J; Lockhart T; Fujiwara R; Radominska-Pandya A; Fantegrossi WE
    J Pharmacol Exp Ther; 2019 Feb; 368(2):146-156. PubMed ID: 30420360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The next generation of synthetic cannabinoids: Detection, activity, and potential toxicity of pent-4en and but-3en analogues including MDMB-4en-PINACA.
    Krotulski AJ; Cannaert A; Stove C; Logan BK
    Drug Test Anal; 2021 Feb; 13(2):427-438. PubMed ID: 32997377
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.